Triple-Negative Breast Carcinoma — Trials

Triple-Negative Breast Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

948 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 416
Recruiting: 234
Ph III recruiting: 21
Growth YoY: +2.4%
Industry share: 31%
Top sponsor: Fudan University
Termination share: 47%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (167)

clinicaltrialsPublishedShowing 51–100 of 948 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06245889	PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC(NeoADAPT)	recruiting	Phase 2	30	Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER	1	Sep 3, 2026	clinicaltrials
NCT06337084	Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors	active not recruiting	Phase 1	12	Monopar TherapeuticsINDUSTRY	1	Sep 3, 2026	clinicaltrials